ARZNEIMITTEL, GEEIGNET ZUR VORBEUGUNG GEGEN BEZIEHUNGSWEISE BEHANDLUNG VON ERKRANKUNGEN DES HERZ/KREISLAUF-SYSTEMES

摘要

The compositions contain 0.5 to 50% by wt. of selenium-containing alga and 99.5 to 50% by wt. of C18-22 fatty acids containing at least two unsaturated bonds or the derivatives thereof, optionally in admixture with carriers and/or additives and antioxidants commonly used in the pharmaceutical industry.